These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24319259)

  • 1. Pfizer's open data policy should include trials of off-label uses, say critics.
    Kmietowicz Z
    BMJ; 2013 Dec; 347():f7327. PubMed ID: 24319259
    [No Abstract]   [Full Text] [Related]  

  • 2. EFPIA-PhRMA's principles for clinical trial data sharing have been misunderstood.
    Doshi P
    BMJ; 2013 Aug; 347():f5164. PubMed ID: 23963563
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissemination of information on the off-label (unapproved) use of medication: a comparative analysis.
    Jansen RM
    Med Law; 2011 Mar; 30(1):115-32. PubMed ID: 21528801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA draft guidance on adaptive design clinical trials: Pfizer's perspective.
    Chuang-Stein C; Beltangady M
    J Biopharm Stat; 2010 Nov; 20(6):1143-9. PubMed ID: 21058110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMA's proposal to vet drug research that uses its data is "outdated," say critics.
    Kmietowicz Z
    BMJ; 2014 Aug; 349():g5076. PubMed ID: 25114275
    [No Abstract]   [Full Text] [Related]  

  • 6. Media coverage of off-label promotion: a content analysis of US newspapers.
    Joshi AD; Patel DA; Holdford DA
    Res Social Adm Pharm; 2011 Sep; 7(3):257-71. PubMed ID: 21272550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The e-recruitment of participants for clinical trials.
    Ehrenberger HE
    IRB; 2003; 25(4):16-7. PubMed ID: 14649250
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of off-label marketing regulations in the post-Sorrell era.
    Iraggi J
    Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338
    [No Abstract]   [Full Text] [Related]  

  • 9. Redacted policy on sharing drug trial data in Europe.
    Groves T; Weber W
    BMJ; 2014 May; 348():g3561. PubMed ID: 24870506
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer.
    Mullins CD; Montgomery R; Abernethy AP; Hussain A; Pearson SD; Tunis S;
    J Clin Oncol; 2012 Feb; 30(6):661-6. PubMed ID: 22253467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding informed consent for participation in international health research.
    Jegede AS
    Dev World Bioeth; 2009 Aug; 9(2):81-7. PubMed ID: 18637943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial and error.
    Printz C
    Cancer; 2013 Feb; 119(3):471-2. PubMed ID: 23341304
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to patient-level data from GlaxoSmithKline clinical trials.
    Nisen P; Rockhold F
    N Engl J Med; 2013 Aug; 369(5):475-8. PubMed ID: 23902490
    [No Abstract]   [Full Text] [Related]  

  • 14. Europe. Drug watchdog ponders how to open clinical trial data vault.
    Rabesandratana T
    Science; 2013 Mar; 339(6126):1369-70. PubMed ID: 23520086
    [No Abstract]   [Full Text] [Related]  

  • 15. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 16. Blockbuster dreams for Pfizer's CDK inhibitor.
    Guha M
    Nat Biotechnol; 2013 Mar; 31(3):187. PubMed ID: 23471056
    [No Abstract]   [Full Text] [Related]  

  • 17. GlaxoSmithKline opens the door on clinical data sharing.
    Harrison C
    Nat Rev Drug Discov; 2012 Dec; 11(12):891-2. PubMed ID: 23197021
    [No Abstract]   [Full Text] [Related]  

  • 18. Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis.
    Garber K
    Nat Biotechnol; 2011 Jun; 29(6):467-8. PubMed ID: 21654650
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to patient-level trial data--a boon to drug developers.
    Eichler HG; Pétavy F; Pignatti F; Rasi G
    N Engl J Med; 2013 Oct; 369(17):1577-9. PubMed ID: 24144395
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug industry pledge on access to trial data is met with scepticism.
    O'Dowd A
    BMJ; 2013 Jul; 347():f4829. PubMed ID: 23900827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.